Drug intelligence / Profile preview

myrcene

Development stage: Phase 1
Modality: Classical Binding Small Molecules → Small Molecules
Administration: Oral, Topical, Inhalation

Overview

Myrcene is a naturally occurring monoterpene found abundantly in various plant species including hops, cannabis, lemongrass, thyme, and mangoes. It functions as a flavoring and aroma agent in food and beverages, and is also used in cosmetics, soaps, and detergents. Myrcene exhibits several biological properties including sedative, anti-inflammatory, analgesic, antioxidant, and antimicrobial effects.

Other names: β-myrcenebeta-myrcene7-methyl-3-methylene-1,6-octadiene2-methyl-6-methylene-2,7-octadiene3-methylene-7-methyl-1,6-octadiene

Targets

GABRR (GABA-A receptor subunit rho)TRPV1 (Transient receptor potential cation channel subfamily V member 1)

Beyond the preview

Go deeper on myrcene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on myrcene.

Explore the full profile